Jefferies Starts NxStage Medical (NXTM) at Buy, Price Target $27
Tweet Send to a Friend
Jefferies initiates coverage on NxStage Medical (NASDAQ: NXTM) with a Buy rating and a price target of $27. The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
